About
Technology
Pipeline
People
News
Contact
Home
About Us
Technology
Pipeline
Our People
News
Contact Us
Technology
Ionic Liquid Platform
For Oral Biologics & Peptides
Ionic liquids (ILs) hold the promise of transforming injectable biologics and peptides into oral therapies
IL platform originally designed in Harvard University labs to overcome known barriers for oral delivery
Proprietary compositions developed from ingredients with a history of human exposure to form New Chemical Entities (NCEs)
i2o has developed a 150+ proprietary ionic liquid library with extensive IP and expertise
MEDICI
TM
Drug Delivery System
For Twice Yearly Biologics & Peptides
Small subcutaneous osmotic implants designed to deliver twice-yearly continuous maintenance dosing
Proprietary formulations for keeping APIs stable at body temperatures for multi-year periods of time
Short in-office procedures designed for optimal customer experience and normal office flow
Our Proprietary Cardiometabolic Medicines
ITCA 650 (exenatide twice-yearly Medici
TM
implants)
Additional long-acting GLP-1 receptor agonists (LA GLP-1 RAs)
Several long acting gut peptides to be combined with LA GLP-1 RAs